Standout Papers

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promi... 2016 2026 2019 2022 723
  1. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 (2016)
    Yusuke Ogitani, Tetsuo Aida et al. Clinical Cancer Research

Immediate Impact

6 by Nobel laureates 5 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout

Works of Takehiro Hirai being referenced

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2016 Standout

Author Peers

Author Last Decade Papers Cites
Takehiro Hirai 673 301 260 397 17 994
Lene Melsæther Grøvdal 359 556 98 185 13 887
Lily Yen 633 855 109 240 17 1.2k
Kristina von Boguslawski 403 519 129 131 26 1.0k
Qin Ruan 140 417 123 495 11 1.1k
Elizabeth Cohen–Jonathan 301 550 173 201 16 1.0k
Tsukasa Oyama 269 811 260 89 26 1.3k
Tünde Szatmári 236 491 209 260 28 1.2k
Sandra L. Biroc 563 723 82 184 22 1.3k
Jessica Katz 418 371 56 426 33 1.3k
Ergang Shi 182 714 62 577 14 1.4k

All Works

Loading papers...

Rankless by CCL
2026